A team of scientists from the University of Leicester, UK, have published findings that indicate that vemurafenib, a BRAF inhibitor that has been approved as a treatment for advanced melanomas, cleared the malignant cells from the blood of patient with hairy-cell leukaemia (HCL) who had exhausted all other treatment options. The treatment with vemurafenib led to a complete clinical recovery in a number of days. Read more here.
Study mentioned: Samuel J, et al. Efficacy of vemurafenib in hairy-cell leukemia. N Engl J Med. 2014 Jan 16;370(3):286-8. PMID: 24428489
No comments:
Post a Comment